In the case of AML, the antineoplastic effect of niclosamide (Figure 3b(iv)) is due to the inhibition of transcription, the binding of NF-κB to DNA, and an increase in ROS levels, which combine to induce apoptosis in leukemic cells [57,92,93,94]. Here, NFKB1 is linked to acute myeloid leukemia.